So what were the major talking points coming out of Cleveland Clinic's Medical Innovation Summit? It certainly wasn't a discussion on the lack of venture capital dollars available for med-tech start-ups - a topic that used to dominate conversations a few years back. Nor was it about the Affordable Care Act. No, the major talk at this year's Medical Innovation Summit, which was held last week, revolved around companion diagnostics. Look for new and exciting pharmaceuticals to be married to diagnostic tests for the foreseeable future. It seems in nearly every other panel something about combination diagnostics was mentioned. One...
Cardinal Health (Dublin, Ohio) said that its MynxGrip Vascular Closure Device recently received FDA approval for use to close femoral veins. The MynxGrip device is now indicated for use to seal 5F, 6F and 7F femoral arterial and femoral venous access sites.
In one of the largest acquisitions in the diagnostics space this year, Laboratory Corporation of America (LabCorp; Burlington, North Carolina) said that it has entered into a definitive agreement to acquire Covance (Princeton, New Jersey) for an enterprise value of $5.6 billion. Under the terms of the agreement, which has been approved by the boards of both companies, Covance shareholders will receive $75.76 in cash and 0.2686 LabCorp shares for each Covance share they own. Covance shareholders will own about 15.5% of the combined company.
As the health sector's center of gravity shifts toward customers, savvy new players are moving fast to capitalize on the change. These new entrants are poised to shake up the industry, drawing billions of dollars in revenue from traditional healthcare organizations while building lucrative new markets in the burgeoning new health economy, according to a newly released report from PricewaterhouseCoopers (PwC; New York).
CLEVELAND — Five years ago the paradigm between diagnostic firms and pharmaceutical companies was quite different. In an exclusive interview during the recent Cleveland Clinic Medical Innovation Summit and working off the backdrop of this year's theme, "Now it's personal, Cancer Treatment and Personalized Medicine," Myriad Genetics Inc.'s president, Mark Capone, spoke of the broadening reach of diagnostic solutions.
CLEVELAND – The Cleveland Clinic unveiled the wildly popular Top 10 list of medical innovations at the recent Medical Innovations Summit. The list of breakthrough therapies and devices, in its 9th year at the event, was selected by a panel of Cleveland Clinic physicians and scientists.
CLEVELAND — When Angelina Jolie went public about her decision to get a double mastectomy, genetic testing received a much higher profile than it had ever had before. The impact of such diagnostic tests would probably be a key factor in transforming the current reactive form of healthcare to a proactive model.
CLEVELAND — The Cleveland Clinic unveiled the wildly popular Top Ten list of medical innovations on the last day of its Medical Innovations Summit on Wednesday, the closing day of the four-day-long conference. The list of breakthrough devices and therapies, in its 9th year at the event, was selected by a panel of Cleveland Clinic physicians and scientists.
